Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

How tumors respond to treatment prior to liver transplants may be useful in selecting recipients

03.08.2006
The results of this study appear in the August 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS). The journal is published on behalf of the societies by John Wiley & Sons, Inc. and is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/livertransplantation.

Liver transplantation is widely recognized as an effective treatment for early-stage hepatocellular carcinoma (HCC) and the size and number of tumors, known as the Milan criteria, are traditionally used to determine a patient's eligibility for a transplant. Treating tumors prior to transplant has been used as a strategy to bridge the waiting time before an organ becomes available, but little research has been conducted on whether pre-treatment may influence survival.

Led by Gerd Otto, M.D. of the Department of Transplantation and Hepatobiliopancreatic Surgery at Johannes Gutenberg University in Mainz, Germany, researchers selected 96 HCC patients between May 1996 and May 1998 for periodic transarterial chemoembolization (TACE) prior to liver transplantation. TACE is a treatment where agents designed to halt or reduce tumor growth are injected into the artery supplying the tumor. The treatment was repeated every six weeks and every time a CT scan was performed to assess tumor growth.

Of the 96 patients, some initially met the Milan criteria, which screens for smaller tumors and fewer lesions, and were immediately listed for transplant, while others exceeded the Milan criteria initially but responded to TACE and were subsequently listed, even though some of them ultimately had tumors that exceeded the criteria before receiving a transplant. Ultimately, 16 patients met the Milan criteria and were transplanted and another 34 exceeded the Milan criteria but received a transplant following TACE. Freedom from recurrence after five years was 94 percent in the first group and 75 percent in the second group.

Since freedom from recurrence was not significantly different in patients who met versus patients who exceeded the Milan criteria, the authors conclude that these criteria may not be crucial in predicting recurrence. "Our study suggests that oncological control reached by the scheduled TACE pretreatment during the waiting time is obviously of greater importance for the long-term prognosis than downstaging [reducing tumor size] itself," the author state. "According to our data, favorable tumors seem to be selected with a much higher degree of reliability if the process of tumor control persists during the total waiting time." They maintain that even large or multiple tumors can be successfully treated by liver transplant if they show a favorable response and remain stable during pretreatment with TACE. "This observation may form a basis of biologically more plausible selection criteria rather than simple tumor size or tumor number," they conclude.

In an accompanying editorial in the same issue, Francis Y. Yao, M.D. of the Division of Gastroenterology at the University of California, San Francisco acknowledges that "this article raises the intriguing possibility of looking beyond tumor size and number in selecting patients with HCC for OLT [liver transplant], but without relying on information that requires biopsy of the tumor." He adds that since no upper limits in tumor size and number were used to exclude patients from receiving transplants, one might conclude that all patients would be eligible for a transplant regardless of tumor size as long they responded to a local treatment such as TACE. However, other research contradicts this conclusion and it is likely that an upper limit in tumor size and number exists beyond which a transplant will most likely yield poor results, despite pretreatment. "While the authors advocate using response to TACE alone as a selection criterion for OLT in patients with HCC, questions still remain regarding the practicality of this approach," the editorial states. He concludes that the study's findings support the basic principle behind reducing tumor size in HCC patients before transplant, because this may eliminate the most aggressive tumors. However, response to this type of treatment is probably not enough by itself. The author concludes: "Rather than replacing tumor size and number, response to TACE or other loco-regional therapy should be an important endpoint used in conjunction with an upper limit in tumor size and number in refining the existing selection criteria for OLT."

David Greenberg | EurekAlert!
Further information:
http://www.wiley.com
http://www.interscience.wiley.com/journal/livertransplantation

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Gold shines through properties of nano biosensors

17.08.2017 | Physics and Astronomy

Greenland ice flow likely to speed up: New data assert glaciers move over sediment, which gets more slippery as it gets wetter

17.08.2017 | Earth Sciences

Mars 2020 mission to use smart methods to seek signs of past life

17.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>